| Authors: |
Givon A; Institute of Clinical Pharmacology and Toxicology, Sheba Medical Center, Tel Hashomer, Israel., Tal-Ben Ishay R; Department of Internal Medicine E, Sheba Medical Center, Tel Hashomer, Israel., Naveh L; Department of Internal Medicine E, Sheba Medical Center, Tel Hashomer, Israel., Lakritz A; Department of Internal Medicine E, Sheba Medical Center, Tel Hashomer, Israel., Braun A; Department of Emergency Medicine, Sheba Medical Center, Tel Hashomer, Israel., Kogan M; Department of Emergency Medicine, Sheba Medical Center, Tel Hashomer, Israel., Irony A; Department of Emergency Medicine, Sheba Medical Center, Tel Hashomer, Israel, Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel., Agmon-Levin N; Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel, Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel., Hajyahia S; Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel., Glick K; Intenstive Care Unit, Sheba Medical Center, Tel Hashomer, Israel., Mayan H; Institute of Clinical Pharmacology and Toxicology, Sheba Medical Center, Tel Hashomer, Israel, Department of Internal Medicine E, Sheba Medical Center, Tel Hashomer, Israel, Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel., Loebstein R; Institute of Clinical Pharmacology and Toxicology, Sheba Medical Center, Tel Hashomer, Israel, Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel. |
